Winrevair is the first FDA-approved activin signaling inhibitor therapy for PAH, a mechanism that improves the balance between pro- and anti-proliferative signaling to regulate vascular cell proliferation, an underlying cause of the disease, according to Mercks announcement
For more information: Katherine N
More Consolidated Sleep Fragmented sleep leaves you feeling exhausted regardless of total time in bed
GIP receptor agonism: adds incretin signaling that can synergize with GLP-1 effects on insulin/glucose regulation and appetite pathways
Lipid-permeable analogs of cysteine, such as N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA), have been studied widely to treat cataracts in different animal models
They were developed for different endpoints medical photoprotection versus cosmetic tanning and sexual function so a claim that one tans better or is safer than the other is stitched together from unrelated studies